Literature DB >> 18241198

A critical role in structure-specific DNA binding for the acetylatable lysine residues in HMGB1.

René Assenberg1, Michelle Webb, Edward Connolly, Katherine Stott, Matthew Watson, Josie Hobbs, Jean O Thomas.   

Abstract

The structure-specific DNA-binding protein HMGB1 (high-mobility group protein B1) which comprises two tandem HMG boxes (A and B) and an acidic C-terminal tail, is acetylated in vivo at Lys(2) and Lys(11) in the A box. Mutation to alanine of both residues in the isolated A domain, which has a strong preference for pre-bent DNA, abolishes binding to four-way junctions and 88 bp DNA minicircles. The same mutations in full-length HMGB1 also abolish its binding to four-way junctions, and binding to minicircles is substantially impaired. In contrast, when the acidic tail is absent (AB di-domain) there is little effect of the double mutation on four-way junction binding, although binding to minicircles is reduced approximately 15-fold. Therefore it appears that in AB the B domain is able to substitute for the non-functional A domain, whereas in full-length HMGB1 the B domain is masked by the acidic tail. In no case does single substitution of Lys(2) or Lys(11) abolish DNA binding. The double mutation does not significantly perturb the structure of the A domain. We conclude that Lys(2) and Lys(11) are critical for binding of the isolated A domain and HMGB1 to distorted DNA substrates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241198     DOI: 10.1042/BJ20071613

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Effect of in vivo post-translational modifications of the HMGB1 protein upon binding to platinated DNA: a molecular simulation study.

Authors:  Wenping Lyu Lv; Fabio Arnesano; Paolo Carloni; Giovanni Natile; Giulia Rossetti
Journal:  Nucleic Acids Res       Date:  2018-12-14       Impact factor: 16.971

2.  Structural and biophysical characterization of murine rif1 C terminus reveals high specificity for DNA cruciform structures.

Authors:  Rasa Sukackaite; Malene Ringkjøbing Jensen; Philippe J Mas; Martin Blackledge; Sara B Buonomo; Darren J Hart
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

Review 3.  Structure-specific nucleic acid recognition by L-motifs and their diverse roles in expression and regulation of the genome.

Authors:  Roopa Thapar
Journal:  Biochim Biophys Acta       Date:  2015-03-04

Review 4.  Yeast HMO1: Linker Histone Reinvented.

Authors:  Arvind Panday; Anne Grove
Journal:  Microbiol Mol Biol Rev       Date:  2016-11-30       Impact factor: 11.056

Review 5.  HMG modifications and nuclear function.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

Review 6.  The dynamics of HMG protein-chromatin interactions in living cells.

Authors:  Gabi Gerlitz; Robert Hock; Tetsuya Ueda; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

7.  Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats.

Authors:  Lu-Wen Wang; Li-Kun Wang; Hui Chen; Cheng Fan; Xun Li; Can-Ming He; Zuo-Jiong Gong
Journal:  World J Gastroenterol       Date:  2012-10-28       Impact factor: 5.742

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 9.  Cruciform structures are a common DNA feature important for regulating biological processes.

Authors:  Václav Brázda; Rob C Laister; Eva B Jagelská; Cheryl Arrowsmith
Journal:  BMC Mol Biol       Date:  2011-08-05       Impact factor: 2.946

Review 10.  Lysine acetylation: elucidating the components of an emerging global signaling pathway in trypanosomes.

Authors:  Victoria Lucia Alonso; Esteban Carlos Serra
Journal:  J Biomed Biotechnol       Date:  2012-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.